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Purpose: The recently published Asymptomatic Carotid Atherosderosis Study (ACAS) 
demonstrated the benefit of performing carotid endarterectomy in selected asymptomatic 
patients who have >60% carotid stenoses. It  therefore becomes clinically important o 
identify the subgroups of patients who have a sufficiently high incidence of high-grade 
carotid stenosis to warrant routine carotid duplex screening. 
Methods: To determine the incidence of asymptomatic carotid disease in patients who had 
a chief complaint of daudication, we evaluated 188 patients who had daudication and no 
history of cerebrovascular symptoms. After a complete history was taken and a physical 
examination performed, patients underwent standard lower-extremity noninvasive vas- 
cular laboratory studies and carotid duplex scanning. Carotid duplex findings were 
interpreted by the Strandness criteria. Associated atherosclerotic r sk factors were assessed 
(patient age, male sex, diabetes, hypertension, smoking history, lipid levels, history of 
coronary artery disease, coronary or vascular surgery, and family history of cerebrovascular 
disease). Presence of a carotid bruit was also noted. Univariate analysis, logistic regression, 
and odds ratios were performed to identify subgroups of patients that had an increased 
incidence of significant carotid disease. 
Results: Of the 188 patients with claudication who were screened, 8% had an internal 
carotid artery stenosis of 16% to 49%, 21.8% had a stenosis that exceeded 50%, and 2.7% 
had an occluded internal carotid artery. The presence of a carotid bruit on physical 
examination was predictive of a >_50% internal carotid artery stenosis (p = 0.027). The 
ankle-brachial index was highly predictive of the presence of carotid stenoses in an inverse 
relationship (p = 0.001). Patient age approached significance (p = 0.143). Patients older 
than 65 years of age who had claudication, an ankle-brachial index less than 0.7, and a 
carotid bruit had a 45% incidence of significant carotid disease. The atherosclerotic risk 
factors of male sex, diabetes, hypertension, hyperlipidemia, smoking history, coronary 
history, previous coronary or vascular surgical history, and family history were not 
predictive of the presence of a >50% carotid stenosis. 
Conclusions: In patients who seek medical attention with the chief complaint of daudica- 
tion and who have no cerebrovascular symptoms, there is a 24.5% incidence of a >50% 
internal carotid artery stenosis or occlusion on duplex examination. Select subsets of these 
patients have upwards of a 45% incidence of significant asymptomatic carotid disease. All 
patients who seek medical attention with claudication should therefore undergo routine 
carotid duplex screening to detect asymptomatic high-grade stenosis. (J Vase Surg 
1996;24:572-9.) 
Stroke remains the third leading cause of death in 
the United States, and survivors have significant 
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residual morbidity rates. More than 500,000 new 
strokes occur annually; an estimated 20% to 50% of 
these strokes are caused by extracranial carotid artery 
disease and are therefore potentially preventable. 1,2
The initial mortality rate of an ischemic stroke ranges 
from 15% to 33%, and survivors have an annual 
recurrent stroke rate that approaches 20%. 2.4 The 
economic burden of stroke is enormous, with an 
estimated annual cost of $ 30 billion, s 
Two recent large multicenter prospective ran- 
domized trials demonstrated the benefit of perform- 
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Fig. 1. Estimated probability of carotid stenosis _>50% compared with ABI. 
t 
1.5 
ing carotid endartcrectomy in patients who had >50% 
or >60% asymptomatic stenoses. The Department of  
Veterans Affairs asymptomatic carotid trial prospec- 
tively randomized 444 patients who had _>50% carotid 
stenoscs to either medical or surgical therapy. 6 This 
study demonstrated a ecrease in the ipsilateral stroke 
rate in the surgical group compared with the medical 
group (4.7% vs 9.4%) over a 4-year period; however, 
this difference was not statistically significant because 
of a probable type II error. The Asymptomatic Ca- 
rotid Atherosclerosis Study (ACAS), in a larger group 
of 1662 patients, showed aclear benefit o performing 
carotid endarterectomy in asymptomatic individuals 
who have a _>60% carotid artery stenosis. 7 Over a 
projected 5-year period there was a 55 % risk reduction 
(p = 0.004) ofipsilateral stroke or death with carotid 
endarterectomy compared with medical therapy 
(5.1% vs 11.0%). 
Asymptomatic arotid occlusive disease may be 
detected in several ways: the presence of a carotid 
bruit on physical examination; an asymptomatic 
stenosis identified contralateral to a symptomatic 
lesion; a patient is screened for carotid disease because 
of the presencc of significant atherosclerotic risk 
factors. Population-based screening studies with du- 
plex ultrasonography ave not proved effective, with 
yields in asymptomatic populations of only 2% to 4% 
for the detection of_>50% internal carotid stenoses. 8,9 
Studies that have focused on patients who had cardiac 
disease or atherosclerotic risk factors have demon- 
strated an approximately 10% to 15% incidence of 
asymptomatic carotid disease.2°-12 The purpose of our 
study was to ascertain the prevalence ofasymptomatic 
carotid disease in patients who were referred to a 
vascular surgeon with claudication as their chief 
complaint. 
PATIENTS AND METHODS 
To dctermine the incidence of asymptomatic ca- 
rotid disease in patients who sought medical attention 
with the chief complaint ofclaudication, we evaluated 
188 patients who were refcrred with claudication and 
no history of cerebrovascular symptoms or previous 
carotid surgery. The patients were referred over a 
period of 3 consecutive years to the Vascular Surgery 
Service at Wilford Hall U.S. Air Force Medical 
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Table I. Distribution of duplex findings 
Stenosis No. of patients Percent 
1% to 15% 127 67.5 
16% to 49% 15 8.0 
50% to 79% 38 20.2 
80% to 99% 3 1.6 
Occluded 5 2.7 
Total 188 100 
Centcr. The first 95 patients were obtaincd by review 
of the vascular registry; the remainder wcrc obtained 
prospectively by evaluating 93 consecutive patients 
who were referred to our clinic with claudication. The 
patients' ages ranged from 42 to 85 years (mean, 
64.2 _+ 8.3 years). One hundred forty-two were men 
and 46 were women. Associated atherosclerotic risk 
factors were present in a majority of patients: diabetes 
in 28.7%, hypertension i  64.9%, previous or current 
cigarette smoldng in 94.1%, hypcrlipidemia in 55.9%, 
history of coronary artery disease in 24.0%, myocar- 
dial infarction in 22.3%, coronary artery bypass ur- 
gery in 16.5%, vascular surgery in 50.0%, and family 
history of cerebrovascular disease in 21.3%. The 
presence of a carotid bruit was also evaluated and was 
noted in 92 patients (49%). 
After a complete history was taken and a physi- 
cal examination completed, patients had segmental 
Doppler-derived leg pressures measured, took a 
treadmill test when indicated, and had carotid duplex 
scanning performed. Vascular laboratory studies 
were performed by registered vascular technologists 
in an approved vascular laboratory. The mean ankle- 
brachial index (ABI) in the patient population was 
0.58 in the more symptomatic leg. Treadmill studies 
were performed in 92 patients (49%), usually in 
patients whose ABIs were greater than 0.7. Carotid 
duplex findings were interpreted with the Strandness 
criteria with internal carotid stenoses categorized 
into five groups; <15%, 16% to 49%, 50% to 79%, 
80% to 99%, and occluded. Univariate analysis, lo- 
gistic regression, and odds ratios were performed to 
identify subgroups of patients who had an increased 
incidence of significant carotid disease (_>50% steno- 
sis). Statistical analysis was performed with SAS ver- 
sion 6.03 (SAS Institute Inc., Cary, N.C.). 
RESULTS 
Of the 188 patients with claudication who were 
screened, 8% had an internal carotid artery stenosis of 
16% to 49%, 21.8% had a stenosis that exceeded 50%, 
and 2.7% had an occluded internal carotid artery 
(Table I). Six patients (3.2%) had bilateral _>50% 
carotid stenoses. A univariate analysis was performed 
for each of the associated atherosclerotic r sk factors. 
Analysis howed that he presence of a carotid bruit on 
physical examination was predictive of an internal 
carotid artery stenosis ->50% (p = 0.027). The ABI 
was evaluated as a continuous variable and was found 
to be highly predictive of the presence of a significant 
carotid stenosis in an inverse relationship (p = 0.00 i), 
that is, the lower the resting ABI, the higher the 
incidence of a significant carotid stenosis (Fig. 1). 
Patient age also was evaluated as a continuous variable 
and approached statistical significance (p = 0.143). 
The remaining risk factors of male sex, diabetes, 
hypertension, lipid status, coronary history, previous 
coronary or vascular surgical history, and family 
history were not predictive of the presence of a _>50% 
carotid stenosis (Table II). Stenoses ->50% were 
present in 20 of 84 current smokers (24%), in 22 of 93 
former smokers (24%), and in four of 11 patients who 
had never smoked (36%); therefore, smoldng was not 
predictive of the presence of a _>50% stenosis 
(p = 0.5968). 
A logistic regression analysis was performed, and 
odds ratios were calculated for various subgroups of 
patients (Table III). Patients older than 65 years of 
age who had claudication had a 29% incidence of 
significant carotid disease, compared with a 21% 
incidence in patients younger than 65 years of age 
(odds ratio, 1.35). Patients older than 65 years of age 
who had claudication, an ABI lower than 0.7, and a 
carotid bruit had a 45% incidence of significant carotid 
disease, compared with an 8.3% incidence in patients 
who did not have these risk factors (odds ratio, 5.42). 
A logistic regression model was designed to cal- 
culate the probability (p) of a carotid stenosis ->50% as 
a function of the ABI and the presence of a carotid 
bruit. The model is plotted in Fig. 1. If one applies this 
model to the actual data, assuming a false-negative 
rate of 10%, then a false-positive rate of 72% and 
specificity rate of only 25% results. 
DISCUSSION 
Two recent multicenter prospective randomized 
trials of carotid endarterectomy and aspirin versus 
aspirin alone have established the benefit of surgical 
treatment of asymptomatic carotid stcnosis. In thc 
Veteran Affairs trial the reduction in thc relative risk of 
stroke or death was 50% for surgical therapy compared 
with medical therapy in patients who had ->50% 
carotid artery stcnosis. 6 In ACAS the rcduction in 
stroke was 53% for surgical therapy compared with 
medical therapy in patients who had _>60% stenosesf 
It therefore becomes clinically important to idcntify 
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Table II. Predictive value of risk factors for >_50% carotid stenosis 
Patients with risk factors Patients without risk factors p 
Male sex 32 of 142 (23%) 14 of 46 (30%) 0.279 
Bruit 29 of 92 (32%) 17 of 96 (18%) 0.027 
Diabetes mellitus 15 of 54 (28%) 31 of 134 (23%) 0.503 
Hypertension 32 of 122 (26%) 14 of 66 (21%) 0.445 
Hyperlipidemia 26 of 105 (25%) 20 of 83 (24%) 0.916 
Coronary disease 10 of 45 (22%) 36 of 143 (25%) 0.688 
Myocardialinfarction 9 of 42 (21%) 37 of 146 (25%) 0.604 
Family historystroke 11 of 40 (27%) 26 of 112 (23%) 0.571 
Prior cardiac surgery 9 of 31 (29%) 37 of 157 (24%) 0.744 
Prior vascular surgery 24 of 94 (25%) 22 of 94 (23%) 0.734 
Table III. Odds ratios for significant risk factors 
Odds of >50% carotid stenosis Odds of >50% carotid stenosis 
Patient subgroup with risk factor without risk factor Odds ratio 
Age >65 23 of 80 (29%) 23 of 108 (21%) 1.35 
Presence of carotid bruit 29 of 92 (32%) 17 of 96 (18%) 1.78 
Age >65 and presence of carotid bruit 14 of 38 (37%) 8 of 54 (14.8%) 2.50 
Age >65, presence of carotid bruit, 13 of 29 (45%) 2 of 24 (8.3%) 5.42 
and ABI <0.7 
the subgroups of patients who have a high incidence 
of occult carotid stenosis who would benefit from 
routine carotid duplex screening examinations. 
Population-based screening for carotid stenosis 
has not proved cost-effective in unselected patient 
populations. Ramsay et al.s evaluated 102 asymptom- 
atic volunteers older than 50 years of age with duplex 
and oculopncumoplethysmography. These investiga- 
tors reported an 11% incidence of carotid disease; 
however, only one patient had a stenosis of 60% to 
79%, and one patient had an occluded internal carotid 
artery. The remaining patients had stenoses <60%. In 
their population there was a 20% incidence of periph- 
eral vascular disease (defined as an ABI lower than 
0.92), but no patient complained of claudication. 
Screening of this population would offer only a 2% 
yield of potentially remedial high-grade carotid oc- 
clusive disease. Colgan et al. 9 performed duplex 
scanning in 348 unselected volunteers who did not 
have symptoms. They noted that 107 subjects (31%) 
had evidence of extracranial carotid artery disease; 
however, only 13 (4%) patients were identified as 
having a _>50% stenosis of the internal carotid artery, 
and only three (1%) with _>80% carotid stenoses. 
Several studies have analyzed patients who under- 
went cardiac or peripheral vascular surgery who 
therefore had a higher prevalence of atherosclerotic 
risk factors. Turnipseed et al.13 performed carotid 
duplex imaging before surgery in 330 patients who 
required coronary artery surgery (170) or peripheral 
vascular surgery (160). They noted a high percentage 
of carotid bruits in the patients who had peripheral 
vascular disease (PVD; 44%) compared with the 
patients who had coronary artery disease (16%). In 
those patients who had a bruit there was a 54% 
incidence of significant carotid disease. The patients 
who had PVD had a 52% incidence of significant 
carotid disease compared with 11.7% of patients who 
underwent coronary surgery. In their study, however, 
33% of patients had a history ofneurologic symptoms, 
and 43% of the patients who had PVD were symp- 
tomatic from their carotid disease. 
Barnes et al. 1° prospectively screened before coro- 
nary or peripheral rterial reconstruction 449 patients 
who were initially asymptomatic from a cerebrovas- 
cular standpoint. Using continuous-wave Doppler 
ultrasonography to screen patients, they noted that 
the prevalence of carotid artery disease was signifi- 
cantly higher in patients who had PVD (28.8%) than 
in patients who had CAD ( 15.1%, p < 0.05 ). Patients 
who had asymptomatic carotid artery disease had an 
increased risk ofneurologic events (15.3%) compared 
with patients without carotid disease (0.8%) during 
2-year follow-up. In addition, there was an increased 
risk ofperioperative and late death (10.6% and 9.2%, 
respectively) in patients who had asymptomatic ca- 
rotid disease compared with patients who did not 
(0.3% and 0.8%, respectively, p < 0.001). 
On the basis of the above studies that showed an 
increased incidence of carotid disease in peripheral 
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vascular surgery patients, recent studies have focused 
on the prevalence of asymptomatic carotid artery 
disease in this subpopulation ofpatients. Ahn et al. 14 
reviewed the duplex scans of 78 patients who under- 
went screening solely because peripheral vascular 
disease was present. They noted that 14% of this 
patient population had carotid stenoses _>50%. They 
excluded patients who had cervical bruits, and they 
did not correlate the severity of the peripheral vascular 
disease to the presence of carotid stenoses. In their 
analysis the risk Factors of male sex, age >68 years, 
hypertension, and previous cardiovascular surgery 
correlated with a 45% incidence of_>50% carotid 
stenosis. They concluded that routine carotid duplex 
screening isindicated in elderly patients (age >68 yrs) 
who have peripheral vascular disease. 
Fowl et al.~2 screened two patient groups in a 
Veterans Hospital setting for the presence of 
asymptomatic carotid stenosis. The first group con- 
sisted of 153 patients who had no history of PVD, 
and the second group consisted of 116 patients who 
were known to have significant PVD. They noted, 
using duplex screening, a 6.5% incidence of _>50% 
carotid stenosis in the first group, compared with 
12.0% for the patients in the second group 
(p = 0.058). They recommended aggressive carotid 
surveillance in asymptomatic patients who have mul- 
tiple atherosclerotic risk factors. 
Gentile et al.15 reviewed 225 patients who under- 
went infrainguinal revascularization procedures and 
had no previous carotid surgery or cerebrovascular 
symptoms. The majority of procedures (67%) were 
performed for limb salvage, the remainder for claudi- 
cation. In this group of patients who had severe 
peripheral vascular disease, a 28.4% incidence of 
hemodynamically significant stenoses (_>50%) or oc- 
clusion was detected. By logistic regression analysis, 
the presence of a carotid bruit (p < 0.001) and the 
presence of rest pain (p = 0.006) were associated with 
_>50% carotid stenosis. Of the 74 patients who had 
claudication, 23% had an asymptomatic carotid steno- 
sis >50%, compared with 31% in the limb salvage 
group. Among the 62 patients who had a carotid 
bruit, 36 (58%) had an asymptomatic carotid stenosis 
>50%. In this study eight patients who had carotid 
stenoses _>80% subsequently underwent elective ca- 
rotid endarterectomy. 
Our study focused on patients who sought medi- 
cal attention at a vascular surgery clinic with the chief 
complaint of claudication, and it demonstrated a 
24.5% incidence of >50% carotid stenosis or occlu- 
sion. This finding correlates well with that of the study 
by Gentile et al.15 in the incidence of asymptomatic 
disease and the importance of certain risk factors. As 
expected, a high percentage of athcrosclerotic risk 
factors was present in our patient population. The risk 
factors of increasing age, worsening severity of PVD, 
and the presence of a carotid bruit were associated 
with significant carotid disease. 
The question arises whether all patients who have 
claudication should be screened for carotid disease or 
whether screening should be limited to select sub- 
populations. In 24 patients who were 65 years of age 
or older, did not have a bruit, and had an ABI greater 
than 0.7, there were still two patients who had carotid 
disease. The utility of logistic regression analysis to 
predict he presence of significant carotid stenosis was 
explored, but proved to be suboptimal. To maintain 
sensitivity (a false-negative rate of 10%) the equation 
resulted in a false positive rate of 72%. We therefore 
conclude that all patients who seek medical attention 
for claudication warrant carotid screening for the 
detection of asymptomatic disease. 
In today's era of economic onstraint in medicine, 
it becomes necessary to demonstrate cost-effective- 
ness, especially when proposing screening tests for 
asymptomatic disease. We performed a theoretic ost 
analysis for the patient population involved in our 
study. The Medicare reimbursement forperformance 
of a carotid duplex examination is approximately 
$170. The cost of carotid endarterectomy is estimated 
at $10,000 in our institution. Estimates of the total 
cost of stroke in the United States vary widely, in part 
because of the difficulty estimating the indirect cost 
that results from disability and death. A 1993 estimate 
placed the total annual cost of stroke at $30 billion 
(including direct and indircct costs), s With approxi- 
mately 500,000 new strokes annually, the average cost 
of an ischemic stroke would thus be in the range of 
$ 60,000. If all 188 patients underwent carotid uplex 
screening to detect 46 potentially operative lesions, 
and assuming that the ACAS data hold true for 5-year 
extrapolated stroke risk with medical versus operative 
therapy (11% vs 5.1%), the screening program would 
result in a total cost of $121,000 per stroke avoided. 
Health care programs that have a cost-effectiveness of 
$40,000 per quality year of life gained are currently 
considered as being cost-effective. 16'17 The estimated 
survival rate of patients who undergo surgery for 
peripheral vascular disease is52% at 10 years.iS There- 
fore, assuming an average 8- to 10-year survival rate 
after prophylactic arotid endartcrectomy in this 
patient population, the therapy clearly would be 
cost-effective when compared with other recom- 
mended screening programs. 
These calculations assume that operative interven- 
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t ion would  be per formed for every pat ient who had a 
>50% asymptomatic stenosis. Realistically, this over- 
estimates the number  o f  patients who would  actually 
undergo carotid endarterectomy. We do not  yet have 
long-term fol low-up pat ient data to determine the 
percentage o f  patients who actually underwent  ca- 
rot id endarterectomy in this series. Currently, we are 
per forming CEA in asymptomatic patients who have 
_>70% stenoses. We estimate that screening for asymp- 
tomatic carotid disease in patients who have claudi- 
cation would  result in prophylactic carotid endarter- 
ectomy being per formed in 5% of  the patients in this 
populat ion.  In  addit ion, those patients who have 50% 
to 70% stenosis would  benefit from serial scanning, as 
they appear to have a higher l ikel ihood of  eventual 
progression to a h igh-grade stenosis. 
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D ISCUSSION 
Dr. Ralph B. Dilley (La Jolla, Calif.). I would like to 
compliment Dr. Marek and his colleagues on a well- 
presented paper and a well-studied group of patients who 
were screened for carotid artery disease while being evalu- 
ated for claudication. This is another prevalence study, 
several of which have been reported since the results of the 
VA study and ACAS have been published, and it attempts to 
answer the question of which patients hould be screened 
for the presence of asymptomatic carotid artery disease. In 
this report, patients who sought medical attention for 
claudication at a vascular clinic were studied, and the 
authors found a 25% incidence of significant carotid artery 
disease, which is similar to the incidence found in other 
reports in the literature. Most of the other eports, however, 
looked at patients who underwent operation for their 
vascular disease and thus were more likely to have severe 
disease. 
The University of Washington criteria were used to 
establish the degree ofstenosis, and ABI and a carotid bruit 
were predictors of a significant stenosis. If  the patient's age 
was greater than 65 years and if the patient had a carotid 
bruit and an ABI less than 0.7, 45% had significant stenosis. 
But because none of the variables were sufficiently powerful 
to pick up all significant stenoses, the authors conclude that 
all patients who seek medical attention for evaluation of 
claudication should be studied for asymptomatic carotid 
disease. Using ACAS data, they also suggest hat such a 
policy is cost-effective. 
Although the ACAS and VA results are impressive, there 
are several aspects of these studies that are sobering. First, 
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the VA study did not show significantly fewer strokes in the 
surgically treated group, but it was close to significant. 
Second, in ACAS a _>60% lesion was calculated from 
arteriograms and is not the same as that calculated from the 
University of Washington criteria unless ome modification, 
as suggested by Moneta and colleagues, is used. Third, it is 
difficult to understand why a 60% asymptomatic lesion 
benefits from operation, as is the case in ACAS, and not a 
60% symptomatic lesion, as is the case in the North 
American Symptomatic Carotid Endarterectomy Trial. 
Fourth, the benefits of operation in ACAS are modest at 
best, with an absolute risk reduction of 5.9% in the surgical 
group, or just greater than 1% per year. This means that at 
the second year 67 operations must be performed to prevent 
one stroke, and at the fifth year 20 operations must be 
performed to prevent one stroke. Finally, in ACAS there was 
no benefit seen with operation in women, no difference in 
various deciles ofstenosis, and the major stroke rate was the 
same in the medically and surgically treated groups. 
Although these may be type II errors, I have concluded 
that we must be cautious in recommending widespread 
screening as being cost-effective, specially in an elderly 
population. In fact, in the members of our HMO Medicare 
group, who are all over age 65 and who had an average age 
at the time of evaluation of 73 years (64 in this report), 
cerebral blood flow studies are not approved unless a carotid 
bruit is present or the patient is scheduled to undergo a 
cardiac or a peripheral vascular operation. 
Is the cohort of patients who have _>50% stenoses till 
too large? What percentage of patients would have had 
significant stenosis if you had used 70%, the level many still 
believe is required in the asymptomatic patient for consid- 
eration of a prophylactic operation? 
How do you plan to use the data you have developed? 
Your cost-analysis a sumes that all patients who have _>50% 
stenoses undergo operation. Are you recommending op- 
eration for patients who have 50% to 70% stenosis, even the 
elderly? !f not, how often should patients who have these 
lessor degrees of obstruction be studied, and were these 
additional studies included in your cost analysis? 
About 28% of your patients were diabetic; how did they 
affect your ABI measurements, and were they eliminated 
from the analysis if vessels were noncompliant? 
Again, I believe this is an important paper, and the 
results of studies such as this will be closely watched by 
managed care organizations. 
Dr. John Marek. This study was planned and the data 
acquired before the ACAS study was concluded, and we 
therefore used a 50% to 79% criteria. We didn't go back and 
calculate how many fell into the _>60% or _>70% categories. 
Looldng at the study that was published recently by 
Gentile et al. 15 in their similar cohort of patients they 
estimated that when they went back and calculated the 
precise degree of stenosis that approximately half of those 
patients would fall instead of >50% stenosis into the 
category of_>60% stenosis. All I can say is that there was a 
small subset, approximately 2% to 3% of the patients, who 
were in the 80% to 99% category, and I would estimate that 
probably a total of 5% of these patients went into the >70% 
category. 
As to how to use our data, I think that this was really an 
epidemiologic study. We weren't making any recommen- 
dations that all patients who have asymptomatic disease 
should undergo carotid endarterectomy because we believe 
that despite the ACAS trial, the data is still out on whether 
patients who have the lower grades of stenosis should 
undergo an operation. 
We are currently prospectively observing patients in our 
vascular clinic who have claudication, what changes this will 
make in our operative plans on the patients who currently 
have claudication and asymptomatic disease, and how many 
of these patients are going to undergo an operative inter- 
vention. 
The question regarding patients who have diabetes, 
approximately 28% of the patients had diabetes. The ma- 
jority of patients who had incompressible vessels had 
treadmill studies performed. The patients who had com- 
pletely incompressible vessels or supersystolic pressures 
were deleted from the study. 
Dr. J. Dennis Baker. As Dr. Dilley commented, we 
need to challenge the need to screen for patients who have 
_>50% stenoses. The ACAS study selected patients who had 
_>60% stenoses, but a special cutoff point for the Doppler 
data was developed for each laboratory so as to reduce the 
rate of false-positive r sults. The special criteria tended to 
correlate with what most laboratories are using to detect 
stenoses greater than 75% or 80%. If it is decided that the 
critical person to find is the one who has a _>75% stenosis, 
then your study would only yield 4% of unsuspected lesions, 
fewer if patients who have bruits are eliminated. 
A very practical question is how do you propose we pay 
for this screening? At this time, Medicare specifically ex- 
cludes payment for screening studies, and I do not antici- 
pate a change in this policy, despite the results of ACAS. 
Dr. Marek. I believe that there now have been three 
studies that came to the conclusion that it is probably 
warranted to screen for patients who have significant PVD. 
With regard to the question of cost-effectiveness and 
who is going to pay for it, I think if we show with 
continued studies that this is a cost-effective procedure 
that eventually Medicare will pay for it. Other centers 
screen patients who are being admitted to the hospital to 
undergo revascularization procedures, and Medicare will 
pay for those studies. 
I think that the natural history of patients who have a 
50% to 60% asymptomatic stenosis is still up in the air. The 
following paper addresses the issue of what is the outcome 
and what number of patients are going to eventually 
progress to require a carotid endarterectomy. I think those 
data are still out. 
So I don't know what the natural history of these 50% 
to 60% stenoses is and whether today's patients would 
eventually require carotid endarterectomy and warrant 
earlier operation and aggressive screening. 
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Dr. Wesley S. Moore (Los Angeles, Calif.). I was very 
interested in how you derived your calculations for cost- 
effectiveness. In your theoretic omputation, you assumed 
that he cost of a stroke was $ 300,000. I have tried very hard 
to get these data, and the number of publications that show 
the cost of a stroke are rather few. 
The most recent one that I 'm aware of is one published 
by Norris. That report is somewhat biased by the difference 
in costs oftaldng care of these patients in Canada versus the 
United States. In that setting, however, they reported that 
the cost was somewhere between $25,000 and $40,000 to 
pay for the medical costs of a patient who has a stroke. This 
calculation did not take into account loss of productivity. 
Could you tell us where you got this $300,000 figure? 
I'd love to use it. 
Dr. Marek. I have seen a couple of different figures in 
the literature, and the initial one I saw was a $188,000 total 
by Dr. Moore, and that was in, ifI remember correctly, 1988 
dollars. The range that I saw most recently, and the reason 
I use that figure, was in a discussion with Dr. Taylor from 
Oregon, who has reviewed this issue and cited the cost of 
$300,000 to $500,000 for a single ischemic stroke. 
Dr. Moore. Are those published ata? 
Dr. Marek. It was in the discussion of the paper by Dr. 
Gentile and his colleagues from the University of Oregon, 
and he cites, although e didn't cite the actual references, 
that he has reviewed five to six papers on this issue, and 
therefore came up with that criteria. 
Dr. John M. Porter (Portland, Ore.). I want to 
emphasize what Dr. Baker said. We are on the Oregon 
Medicare Carriers Advisory Panel. You all must be aware 
now that he national Medicare carrier medical advisers have 
put out a document as to what Medicare will and will not 
pay for in the vascular laboratory. 
Carotid screening is specifically excluded. Dizziness is 
specifically excluded. They also give you criteria under 
which you can follow-up carotid bypass procedures and leg 
bypass procedures after surgery. 
If you are a vascular laboratory director, you know that 
about 60% to 80% of your patients are Medicare patients, 
and Medicare is getting billed. You have got to be critically 
careful for what tests you're billing Medicare. They promise 
us that we're all going to be audited. They're going to 
perform random audits, and any violations they find will 
lead to restitution with penalty as applied to your entire 
volume. 
All of you who are running vascular laboratories, please 
talk to your local Medicare medical director and get this list 
of criteria for vascular laboratory use. Screening tests are 
specifically prohibited. 
Dr. Joseph L. Mills. IfI can help rcspond to that, there 
is a national document, but what I found when I changed 
states was that every state and every carrier doesn't neces- 
sarily follow the national guidelines. The only way we're 
going to change that is by generating some data that show 
what the yield of screening is. 
So, for example, in Arizona now they will pay for 
scrccning of an asymptomatic carotid bruit, which they 
would not do in the past. This particular study was per- 
formed in a military setting, in which cost was not an issue. 
So our only goal was to try to identify high-risk 
patients, and I think we have done that because clearly 
you're going to see from other papers, including the next 
one, that patients who start out with a >50% stenosis and 
multiple risk factors have a high likelihood of progressing. 
So by this study we have separated patients into two 
groups: a low-risk group, which is about 75% with minimal 
carotid disease which has a known low stroke risk, and 
another subset of patients that should probably be ob- 
served more closely. 
I think that if other centers can reproduce these data we 
could submit his to our local carriers and develop criteria 
that will allow selective screening. Clearly, if we have a 
provcn treatment for high-grade asymptomatic carotid 
stenoses, we are going to have to define how we identify 
these patients and which patient subgroups hould be 
screened. 
Dr. Porter. Dr. Mills, you're assuming that there's a 
certain logic in the Medicare people, and there is no logic. 
We posed the question to the individual who formulated the 
guidelines, "What about ACAS?" He said, "Forget it. 
We're not going to pay for screening tests." 
Now, each state has the option to activate those criteria 
whenever they want o. That's what our carrier director told 
us. In Oregon it's going to go into effect this summer. 
Other states are going to activate that list at different time 
schedules, but the list is very definite. 
Dr. Baker. Although most of the issues regarding 
Medicare payment policics are determined locally by the 
carriers, the issue of screening is different. Federal legisla- 
tion has banned screening except for specifically designated 
tests, such as mammograms and Pap smears. Only by an act 
of Congress can carotid screening be added as a benefit 
under Medicare. In view of the current battles over the 
funding of health care, I don't anticipate this happening in
the near future. 
